1. 2023
  2. Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis

    Liem, S. I. E., Neppelenbroek, S., Fehres, C. M., Wortel, C., Toes, R. E. M., Huizinga, T. W. J., Scherer, H. U. & de Vries-Bouwstra, J. K., 1 Feb 2023, In: Seminars in arthritis and rheumatism. 58, 152136.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of autoimmunity. 135, 102984.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 18F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients

    de Jongh, J., Hemke, R., Zwezerijnen, G. J. C., Yaqub, M., van der Horst-Bruinsma, I. E., van de Sande, M. G. H., van Kuijk, A. W. R., Voskuyl, A. E. & van der Laken, C. J., Feb 2023, In: European journal of nuclear medicine and molecular imaging. 50, 3, p. 756-764 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    Merola, J. F., Landewé, R., McInnes, I. B., Mease, P. J., Ritchlin, C. T., Tanaka, Y., Asahina, A., Behrens, F., Gladman, D. D., Gossec, L., Gottlieb, A. B., Thaçi, D., Warren, R. B., Ink, B., Assudani, D., Bajracharya, R., Shende, V., Coarse, J. & Coates, L. C., 7 Jan 2023, In: The Lancet. 401, 10370, p. 38-48 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

    McInnes, I. B., Asahina, A., Coates, L. C., Landewé, R., Merola, J. F., Ritchlin, C. T., Tanaka, Y., Gossec, L., Gottlieb, A. B., Warren, R. B., Ink, B., Assudani, D., Bajracharya, R., Shende, V., Coarse, J. & Mease, P. J., 7 Jan 2023, In: The Lancet. 401, 10370, p. 25-37 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis

    de Jong, T. A., Semmelink, J. F., Denis, S. W., van de Sande, M. G. H., Houtkooper, R. H. L. & van Baarsen, L. G. M., 1 Jan 2023, In: Journal of autoimmunity. 134, 102974.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

    Fatebenefratelli-Sacco Infectious Diseases Physicians group & UMC COVID-19 S3/HCW study group, 1 Jan 2023, In: EBioMedicine. 87, p. 104408 104408.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Lower Metabolic Potential and Impaired Metabolic Flexibility in Human Lymph Node Stromal Cells from Patients with Rheumatoid Arthritis

    de Jong, T. A., Semmelink, J. F., Denis, S. W., Bolt, J. W., Maas, M., van de Sande, M. G. H., Houtkooper, R. H. L. & van Baarsen, L. G. M., Jan 2023, In: Cells. 12, 1, 1.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals

    Frazzei, G., Musters, A., de Vries, N., Tas, S. W. & van Vollenhoven, R. F., Jan 2023, In: Autoimmunity reviews. 22, 1, 103217.

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...179 Next

ID: 19914